2015 American Transplant Congress
The Impact of Microcirculation Inflammation in Predicting Treatment Response for Late Onset Antibody Mediated Rejection
BackgroundThere have been marked advances of immunosuppression. However, management of late onset antibody-mediated rejection (AMR) after 6 months is still challenging. Despite important diagnostic and…2015 American Transplant Congress
Outcomes of Treatment of Late Antibody-Mediated Rejection in Primary Renal Transplant Recipients – A Single Center Experience
Division of Nephrology and Transplant Institute, Henry Ford Hospital, Detroit, MI.
Background: Successful reversal of early post-transplant antibody mediated rejection (AMR) is well documented, but data on the results of treatment of late AMR are lacking.…2015 American Transplant Congress
Poor Renal Function and Increased Mortality in Elderly Recipients of Deceased Donor Kidneys from Elderly Donors
Background: Within the Eurotransplant Senior Program kidneys form donors older than 65 both after cardiac death (DCD) or brain death (DBD) are allocated to recipients…2015 American Transplant Congress
The Relationship Between Age and Morbidity During the First Year Following Renal Transplantation in Patients Receiving Alemtuzumab Induction
Vanderbilt University Medical Center, Nashville.
BackgroundThe elderly (age ≥ 65) represent the largest growing patient population being listed for renal transplant. Immunosuppression in elderly patients presents a unique challenge, with…2015 American Transplant Congress
Pretransplant Assessment of Vascular Calcification as a Risk Factor of Mortality, Graft Loss, and Cardiovascular Events in Renal Transplant Recipients
Nephrology, Hospital Universitario Miguel Servet, Zaragoza, Spain.
AIM: Cardiovascular events are the first cause of mortality in renal transplant recipients (RTRs), and their incidence is not only justified by the traditional CV…2015 American Transplant Congress
Combined Hepatitic/Cholangiopathic Lesion in HIV-HCV Co-Infected Liver Transplant Recipients Associated With Graft Loss
Background: Co-infection with HIV and viral hepatitis results in poorer outcomes following liver transplantation. In this population, complex immune status, extensive drug regimens, and comorbid…2015 American Transplant Congress
Effects of Early Everolimus Use for Immunosuppression in Living Donor Liver Transplant Recipients- An Analysis of 215 Sequential Patients
Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.
Purpose:In our previously published study, we concluded the safety of everolimus (EVR) in early stage after living donor liver transplantation (LDLT). In this large scale…2015 American Transplant Congress
Maximizing Peri-Operative Value-Based Care in Kidney Transplant Induction
1Pharmacy, MUSC, Charleston, SC; 2Surgery, MUSC, Charleston, SC; 3Nephrology, MUSC, Charleston, SC.
Due to the dwindling reimbursement for kidney transplants (KTx), there must be a continuous effort to provide the best value-based care. The purpose of this…2015 American Transplant Congress
Evaluating Outcomes in Multi-Organ Liver Transplant Recipients
Historically, transplant (Tx) program evaluations performed by the Scientific Registry of Transplant Recipients (SRTR) in the US have included only single-organ Txs, except for simultaneous…2015 American Transplant Congress
Neonatal Tolerance: Donor and Host Cells Fuse in Livers of Newborn Mice Injected With F1-Bone Marrow/Spleen Cells
University of Alberta, Edmonton, Canada.
Purpose: Multiple liver cell-types induce immunological tolerance. Indeed liver allografts are often spontaneously accepted in humans and mice. The role of host liver in the…
- « Previous Page
- 1
- …
- 141
- 142
- 143
- 144
- 145
- …
- 170
- Next Page »